/channels/news_feeds/all/term/Takeda/rss en /channels/channels/news/mni-forms-promising-open-science-partnership-takeda-283212 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><h2>Industry and academia team up for the benefit of people suffering from ALS</h2> <p>A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.</p> <p>The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.</p></div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/5d3a0208.jpg?itok=r_RgT6P3" width="160" height="107" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">4 </span><span class="month">December </span><span class="year">2017</span></div></div></div></div></div> Mon, 04 Dec 2017 19:37:18 +0000 webfull 133352 at /channels